Skip to content

Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia

Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03577964
Enrollment
61
Registered
2018-07-05
Start date
2017-09-01
Completion date
2020-04-25
Last updated
2019-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Metabolism Disorders, Pneumonia, Bacterial

Keywords

Pneumonia, Glucose, Infections, Respiratory Tract Infection, Hyperglycemia, Critical Care

Brief summary

Incidence of Pneumonia in Patients with high systemic glucose levels.

Detailed description

Clinical and mechanistic studies have shown that a hyperglycaemic metabolic condition is associated with a higher incidence of infection and consecutive increased morbidity and mortality. The underlying mechanisms in detail are not completely understood. So far it is not clear whether systemic increased glucose levels are caused by a stress reaction of the body through a catabolic metabolism situation as well as a stress-induced insulin resistance, or infections are promoted by hyperglycemia. From in vivo and in vitro studies, a glucose threshold for the lung is known (147 mg / dL), similar to that in the kidney. It can be hypothesized, that an intra-alveolar glucose in turn promotes bacterial growth as a nutrient substrate. The aim of the study is to determine the concentration of glucose in the alveolar space in connection with hyperglycemic conditions, and to demonstrate a higher incidence of pneumonia in this patient group. The study will enroll cardiac surgery patients receiving surgical treatment and expected postoperative ventilation. Systemic blood glucose monitoring is recorded throughout hospitalization, as well as the removal of bronchial aspirates intraoperatively and during ventilation to measure glucose levels and bacterial levels. The incidence of pneumonia is recorded during the postoperative period by means of radiological examinations and / or microbiological examinations.

Interventions

DIAGNOSTIC_TESTGlucose Measurements,

Measurement of glucose Levels in bronchio alveolar secretions

Sponsors

University of Ulm
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women and men over the age of 18 years * voluntary consent to study participation of the patient * Planned cardiac surgery with expected endotracheal ventilation of ≥ 1 day postoperatively

Exclusion criteria

* age \<18 years * pregnancy * Non-able-bodied patients (disempowerment / loss of consciousness, limitation of the ability to express one's own will, for example through disability) * subsequently withdrawn consent * accommodation in an institution on the basis of official or court orders * lack of or insufficient knowledge of German language, whereby the understanding of the written patient education is not guaranteed. * Immunosuppressed patients * Patients with a malignant disease

Design outcomes

Primary

MeasureTime frameDescription
Incidence of pneumonia or lower respiratory tract infection20 days post surgeryThe incidence of pneumonia or lower respiratory tract infection will be determined by chest x-ray, CT-Scan and/or sampling of specimens of the lower tract of the airways.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026